Axel Schambach1, Christian J Buchholz2, Raul Torres-Ruiz3

  • 1Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; REBIRTH Research Center for Translational Regenerative Medicine, Hannover Medical School, Hannover, Germany; German Center for Infection Research, partner site Hannover-Braunschweig, Germany.

Lancet (London, England)
|November 25, 2023
PubMed
概括

基因组编辑推进了基因疗法,扩大了遗传疾病和癌症的治疗选择. 这篇评论探讨了未来患者护理的新可能性,安全性和道德考虑.